ProMIS Neurosciences Inc. (PMN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $29.60M
Last updated: Nov 17, 2026 at 11:05 AM ET
ProMIS Neurosciences Inc. (PMN) Competitors
The companies most similar to ProMIS Neurosciences are OS Therapies (OSTX), Gain Therapeutics (GANX) and Serina Therapeutics (SER). By market cap, ProMIS Neurosciences ranks 10th of the 13 companies on this page; Mink Therapeutics (INKT) is the largest at $47.95M.
Peer Comparison
PMN's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| NanoViricides Inc (NNVC) | $31.41M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mural Oncology plc (MURA) | $35.38M | N/A | N/A | 0.0% | -173.6% | 0.0% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CervoMed Inc. (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $35.13M | N/A | 119.2x | 0.0% | -109.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to ProMIS Neurosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. | |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| NanoViricides Inc (NNVC) | NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. | NNVC competitors |
| Mural Oncology plc (MURA) | Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors... | |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| CervoMed Inc. (CRVO) | CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. | CRVO competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
Frequently Asked Questions About PMN
Who are ProMIS Neurosciences' main competitors?
The companies most similar to ProMIS Neurosciences include OS Therapies (OSTX), Gain Therapeutics (GANX), Serina Therapeutics (SER), INmune Bio (INMB) and Immutep Ltd ADR (IMMP), listed from the closest match.
Who is ProMIS Neurosciences' biggest competitor?
Mink Therapeutics (INKT) is the largest of the similar companies at $47.95M; OS Therapies (OSTX) is the closest match by business profile, size, sector and industry.
How does PMN stock compare with its competitors?
PMN's net margin is 0.0% against a peer median of 0.0%.
Which of ProMIS Neurosciences' competitors pays a higher dividend?
ProMIS Neurosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is ProMIS Neurosciences bigger than its competitors?
No. ProMIS Neurosciences is 10th by market cap among the 13 companies on this page; the largest is Mink Therapeutics (INKT) at $47.95M.
PMN pages: Overview, Earnings, Forecast, Competitors